Prescription drug · NDA AUTHORIZED GENERIC
Haloperidol Decanoate NDC 10147-0921
Haloperidol decanoate 50 mg/mL · Injection · Intramuscular · Patriot Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10147-0921-3 | 10147092103 | 3 AMPULE in 1 BOX (10147-0921-3) / 1 mL in 1 AMPULEMarketed from Jun 17, 2011 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Haloperidol Decanoate
- Generic name (nonproprietary)
- haloperidol decanoate
- Active ingredients
- Haloperidol decanoate — 50 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular
- Labeler
- Patriot Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 018701
- Marketing start
- Listing expires
- Identifiers
- Product ID 10147-0921_2e815b50-b5db-72e4-e063-6294a90afd55SPL ID 2e815b50-b5db-72e4-e063-6294a90afd55SPL set ID 9f0f42a8-5f7c-4be7-93ef-3ec225502cc6RxCUI 1719803, 1719862UNII AC20PJ4101
- Pharmacologic class
- Typical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N410147092103followed by a unit qualifier and the quantityPackage 10147-0921-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Haloperidol decanoate 50 and Haloperidol decanoate 100 are indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 018701
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Patriot Pharmaceuticals LLC | 10147-0922 |